TIM-3 therapy for Alzheimer’s represents a groundbreaking advancement in the field of Alzheimer’s research, leveraging insights from cancer immunotherapy to combat neurodegenerative diseases.A recent study published in *Nature* highlights how blocking the TIM-3 immune checkpoint molecule can empower microglia, the brain's immune cells, to target and eliminate harmful plaques in the brain.